Review highlights potential of cancer immunotherapy plus targeted therapy

The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests "we are finally poised to deliver curative therapies to cancer patients," researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of Cell.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news